Dive Brief:
- The FDA will allow food producers to label their products as "low-FODMAP," enabling companies to more effectively call out ingredients that are easy on the gut and not likely to exacerbate digestive symptoms associated with irritable bowel syndrome.
- The agency affirmed it will not take enforcement action on food companies using the low-FODMAP label. The FDA, which said it does not consider low-FODMAP to be a nutrient content claim, also will not take action on the label as a means of avoidance or statement of special dietary usefulness.
- Low-FODMAP foods are products that are low in fermentable carbohydrates, or sugars that can cause digestive distress. The move by the FDA to allow the label comes after a federal appeals court revived a lawsuit arguing that restrictions violated the First Amendment.
Dive Insight:
FODMAP stands for fermentable oligosaccharides, disaccharides, monosaccharides, and polyols. Consumers on low-FODMAP diets typically avoid foods that are high in these fermentable carbohydrates, such as onions, dairy and garlic.
Low-FODMAP diets are temporary and restrictive eating plans that can help those with IBS or other digestive problems alleviate symptoms. The rise of GLP-1s may expand the use case for the label, as weight loss medications slow the digestive process and can cause bloating or gas.
Gourmend Foods, which specializes in low-FODMAP broths and seasoning kits, challenged the FDA's stance in 2023. The company had applied for approval to use the label for beef broth through the USDA. It was denied after the department consulted with FDA regulators.
“I hope this change of policy will make it easier for people who are suffering from debilitating stomach issues to find the foods that make them feel better,” Ketan Vakil, owner of Gourmend Foods, said in a statement. “For years Gourmend has had to fear that we’d be punished for truthfully labeling our products, but now that fear is gone, and we can make it easier for people to find these products.”
While the FDA has said it will not take enforcement action against Low-FODMAP labels, that doesn't insulate companies against the risk of consumer litigation. Brands are currently facing a surge in lawsuits around zero-sugar labels for products containing allulose despite a pledge from the agency that it would not take enforcement action.
Up to 45 million people in the U.S. suffer from IBS, according to the International Foundation for Gastrointestinal Disorders. In one study, 70% of those with IBS were able to alleviate symptoms using a low-FODMAP diet.
“Businesses have the right to tell the truth about their products, and their customers have the right to hear that truthful information without government getting in the way,” said Justin Pearson, managing attorney for the Institute for Justice, which represented Gourmend in the case. “The old rules weren’t just hard to digest, they were unconstitutional, and we’re glad to see these changes.”